Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy [NA]
This clinical trial entry describes the VIP trial, a randomized study evaluating changes in volatility with psychotherapy for schizophrenia,…
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: A Study of ANAVEX3-71 in Adults With Schizophrenia [Phase 2]
An update on a Phase 2 study of ANAVEX3-71 in adults with schizophrenia, noting that the trial is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia [NA]
A completed clinical trial evaluating the overall effects of CT-156 in people with schizophrenia. The trial was sponsored by Click Therapeut…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia [Phase 3]
A Phase 3 study evaluating the efficacy, safety and tolerability of flexibly dosed paliperidone extended release (ER) in participants with s…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation [Phase 3]
A completed Phase 3 study evaluated transitioning schizophrenia patients stabilized on paliperidone palmitate 1-month to the 3-month formula…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients
A completed study assessing the safety and tolerability of paliperidone palmitate (Invega Sustenna) in Korean patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly
A completed study collecting feedback from patients, physicians, nurses and carers after switching to paliperidone palmitate every three mon…
-
CLINICAL_TRIALS other · 2025-04-27Clinical Trial Update: Sustainable Early Episode Clinic Study (SEEC) [NA]
Janssen-sponsored clinical trial SEEC for schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal
A completed study in Portugal evaluating how paliperidone palmitate affects clinical outcomes and hospital resource use in adults with schiz…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings [Phase 4]
Phase 4 study evaluating paliperidone palmitate for schizophrenia in Rwanda has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study for Schizophrenia Relapse Prediction
A Janssen-sponsored clinical trial evaluating relapse prediction in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities [Phase 4]
A Phase 4 clinical trial sponsored by Janssen evaluated sequential use of oral risperidone followed by paliperidone palmitate in Rwandan hea…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation
This clinical trial update analyzes predictors of functional remission in patients with schizophrenia who were discharged after long-term di…
-
FDA approval · 2025-04-24FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for haloperidol decanoate by Sagent Pharmaceuticals, updating regulatory approval for this long-acti…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: The Effect of a Mindfulness-Based Self-Compassion Program on Care Burden, Life Satisfaction, and Coping Levels of Caregivers of Individuals With Schizophrenia [NA]
A completed clinical trial evaluated a mindfulness-based self-compassion program for reducing caregiver burden and improving life satisfacti…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
A recruiting clinical trial from Central South University is investigating immunoinflammatory state detection and multimodal brain imaging a…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Study To Evaluate The Effect Of A Supratherapeutic Dose Of MK-8189 On The QTc Interval In Participants With Schizophrenia (MK-8189-019) [Phase 1]
Phase 1 trial evaluating the impact of a supratherapeutic dose of MK-8189 on the QTc interval in participants with schizophrenia; results ha…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Neuronal Effects of Exercise in Schizophrenia [NA]
This clinical trial investigates the neuronal effects of exercise in people with schizophrenia and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia [NA]
A completed clinical trial evaluated the effects of low-dose levetiracetam on clinical symptoms, cognition, and hippocampal activity in schi…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation [NA]
This clinical trial assesses cognitive remediation therapy for schizophrenia and its impact on EEG measures and emotional regulation; recrui…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis [NA]
A recruiting trial at Beth Israel Deaconess Medical Center studying mechanisms of response to therapeutic intervention in individuals at cli…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of brexpiprazole for schizophrenia has completed, potentially informing next regul…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: TMS Enhancement of Visual Plasticity in Schizophrenia [NA]
This clinical trial evaluated transcranial magnetic stimulation to enhance visual plasticity in schizophrenia; the study was terminated and …
-
FDA approval · 2025-04-15FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for lurasidone hydrochloride, enabling the generic to be marketed in the United…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders [Phase 2]
Phase 2 clinical trial evaluating the effects of intranasal insulin on neuroimaging markers and cognition in patients with psychotic disorde…